Cargando…
Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
Immunotherapy has become a mainstay of cancer treatment in many malignancies, though its application in breast cancer remains limited. Of the breast cancer subtypes, triple-negative breast cancers (TNBCs) are characterized by immune activation and infiltration and more commonly express biomarkers as...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184866/ https://www.ncbi.nlm.nih.gov/pubmed/34101053 http://dx.doi.org/10.1007/s10555-021-09972-4 |